Glaxosmithkline Share News (GSK)
GSK Share
GSK Share
GSK Share
GSK Share
GSK
GSK Share
GSK Level 2
GSK Live
GSK Broker
GSK Directors
GSK Financial
GSK
GSK Short
GSK
Last checked at -
(Sharecast News) - GlaxoSmithKline announced on Thursday that the US Food and Drug Administration (FDA) approved the company's supplemental New Drug Application (sNDA) for 'Zejula', or niraparib.
Read more
By Carl O'DonnellApril 29 (Reuters) - The U.S. Food and Drug Administration on Wednesday cleared expanded use of GlaxoSmithKline Plc's Zejula as a first option to keep advanced ovarian cancer at bay in women who have responded to chemotherapy.The ...
Read more
LONDON MARKET CLOSE: Stocks Surge As Gilead Offers Renewed Virus Hope
Read moreUK Shareholder Meetings Calendar - Next 7 Days
Read more(Adds comment, background)April 29 (Reuters) - GlaxoSmithKline, the world's largest vaccine maker, said the global push to develop an immunisation against the coronavirus would not lead to widely available products before the second half of next y...
Read moreApril 29 (Reuters) - The chief executive of the world's largest vaccine maker, GlaxoSmithKline, said the global push to develop an immunisation against the coronavirus would not lead to widely available products before the second half of next ye...
Read more* Over-the-counter products division, Shingrix sales beat* Does not anticipate significant delays to drug approvals (Recasts with details on stockpiling, executive comments)By Pushkala Aripaka and Ludwig BurgerApril 29 (Reuters) - GlaxoSmithKline be...
Read more(Sharecast News) - GlaxoSmithKline backed its full-year guidance on Wednesday as it posted a jump in first-quarter turnover, with growth across all three of its business and as sales of shingles vaccine Shingrix surged.
Read more* European stocks rise higher* STOXX 600 +1.5%* Germany's Wirecard plunges 20%* HSBC, UBS, Santander: mixed Q1 results Welcome to the home for real-time coverage of European equity markets brought to you by Reuters stocks reporters. You can share y...
Read more* European stocks rise higher* STOXX 600 +2%* Germany's Wirecard plunges 20%* HSBC, UBS, Santander: mixed Q1 results Welcome to the home for real-time coverage of European equity markets brought to you by Reuters stocks reporters. You can share you...
Read more* European stocks rise higher* STOXX 600 +1.6%* Germany's Wirecard plunges 20%* HSBC, UBS, Santander: mixed Q1 results Welcome to the home for real-time coverage of European equity markets brought to you by Reuters stocks reporters. You can share y...
Read more* European stocks rise higher* STOXX 600 +1.6%* Germany's Wirecard plunges 20%* HSBC, UBS, Santander: mixed Q1 results Welcome to the home for real-time coverage of European equity markets brought to you by Reuters stocks reporters. You can share y...
Read more* European stocks inch higher* STOXX 600 +1.3%, FTSE 100 +1.2%* Germany's Wirecard plunges 20%* HSBC, UBS, Santander: mixed Q1 results Welcome to the home for real-time coverage of European equity markets brought to you by Reuters stocks reporters....
Read more* Oxford clinical trial is latest of handful already begun* Three European firms join forces for vaccine research* Swiss company hopes to get vaccine into use this year (Adds quotes from Wellcome and ReiThera, new byline and dateline)By Kate Kellan...
Read more(Sharecast News) - Hargreaves Lansdown: Deutsche Bank downgrades to sell with a target price of 1,325p.
Read more
Last checked at